Ignite Creation Date:
2025-12-25 @ 4:24 AM
Ignite Modification Date:
2026-02-28 @ 7:29 AM
Study NCT ID:
NCT01580020
Status:
COMPLETED
Last Update Posted:
2016-05-17
First Post:
2012-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Retinal Vein Occlusion | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Macular Degeneration | View |
| None | Macular Edema | View |
| None | Retinal Vein Occlusion | View |
| None | Choroidal Neovascularization | View |
| None | Signs and Symptoms | View |
| None | Retinal Degeneration | View |
| None | Retinal Diseases | View |
| None | Eye Diseases | View |
| None | Venous Thrombosis Sensation Disorders | View |
| None | Dexamethasone acetate | View |
| None | Dexamethasone | View |
| None | Dexamethasone 21-phosphate | View |
| None | BB 1101 | View |
| None | Anti-Inflammatory Agents | View |
| None | Therapeutic Uses | View |
| None | Vision, Low | View |
| None | Signs | View |
| None | Vision Disorders | View |